Code | 2745D | ||||||||||
MA number | EU/1/16/1124/070 | ||||||||||
Product Form: | sol inj 12(3x4)x0,9 ml/22,5 mg (pero napl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | pre-filled pen | ||||||||||
Route of admin.: | Subcutaneous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(3) hybrid application |
MA issued: | 18.08.2016 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 01.07.2021 |